Stringent screening strategy significantly reduces reactivation rate of Tuberculosis in Patients with Inflammatory Bowel Disease on anti-TNF therapy in a TB endemic region

被引：0
|
作者：
Kumar, P. [1 ]
Vuyyuru, S. K. [1 ]
Kante, B. [1 ]
Sahu, P. [1 ]
Goyal, S. [1 ]
Madhu, D. [1 ]
Jain, S. [1 ]
Ranjan, M. K. [1 ]
Mundhra, S. [1 ]
Golla, R. [1 ]
Singh, M. [1 ]
Virmani, S. [1 ]
Gupta, A. [1 ]
Yadav, N. [1 ]
Kalaivani, M. [1 ]
Sharma, R. [1 ]
Das, P. [1 ]
Makharia, G. [1 ]
Kedia, S. [1 ]
Ahuja, V. [1 ]
机构：
[1] All India Inst Med Sci, Dept Gastroenterol & Human Nutr, New Delhi, India
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P531
引用
收藏
页码：I484 / I484
页数：1
相关论文
共 50 条
  • [1] Stringent screening strategy significantly reduces reactivation rate of Tuberculosis in Patients with Inflammatory Bowel Disease on anti-TNF therapy in a TB endemic region
    Kumar, P.
    Vuyyuru, S. K.
    Kante, B.
    Sahu, P.
    Goyal, S.
    Madhu, D.
    Jain, S.
    Ranjan, M. K.
    Mundhra, S.
    Golla, R.
    Singh, M.
    Virmani, S.
    Gupta, A.
    Yadav, N.
    Kalaivani, M.
    Sharma, R.
    Das, P.
    Makharia, G.
    Kedia, S.
    Ahuja, V.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I484 - I484
  • [2] Stringent screening strategy significantly reduces reactivation rates of tuberculosis in patients with inflammatory bowel disease on anti-TNF therapy in tuberculosis endemic region
    Kumar, Peeyush
    Vuyyuru, Sudheer K.
    Kante, Bhaskar
    Sahu, Pabitra
    Goyal, Sandeep
    Madhu, Deepak
    Jain, Saransh
    Ranjan, Mukesh Kumar
    Mundhra, Sandeep
    Golla, Rithvik
    Singh, Mukesh
    Virmani, Shubi
    Gupta, Anvita
    Yadav, Nidhi
    Kalaivani, Mani
    Sharma, Raju
    Das, Prasenjit
    Makharia, Govind
    Kedia, Saurabh
    Ahuja, Vineet
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (11) : 1431 - 1440
  • [3] Stringent screening strategy leads to significant risk reduction of tuberculosis in patients with inflammatory bowel disease receiving anti-TNF therapy: A real world cohort analysis from a TB endemic region
    Kumar, P.
    Vuyyuru, S. K.
    Kante, B.
    Kedia, S.
    Sahu, P.
    Singh, M.
    Virmani, S.
    Yadav, N.
    Gupta, A.
    Sharma, R.
    Makharia, G.
    Ahuja, V.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 178 - 178
  • [4] STRINGENT SCREENING STRATEGY LEADS TO SIGNIFICANT REDUCTION OF TUBERCULOSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE RECEIVING ANTI-TNF THERAPY: A REAL-WORLD COHORT ANALYSIS FROM A TUBERCULOSIS ENDEMIC REGION
    Kumar, Peeyush
    Vuyyuru, Sudheer K.
    Kumar, Bhaskar
    Sahu, Pabitra
    Goyal, Sandeep
    Madhu, Deepak
    Jain, Saransh
    Ranjan, Mukesh K.
    Mundhra, Sandeep
    Golla, Rithvik
    Singh, Mukesh K.
    Virmani, Shubi
    Sharma, Raju
    Makharia, Govind K.
    Kedia, Saurabh
    Ahuja, Vineet
    GASTROENTEROLOGY, 2022, 162 (07) : S870 - S870
  • [5] Serial Tuberculosis Screening in Inflammatory Bowel Disease Patients Receiving Anti-TNFα Therapy
    Abreu, Candida
    Afonso, Joana
    Dias, Claudia Camila
    Ruas, Rogerio
    Sarmento, Antonio
    Magro, Fernando
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (10): : 1223 - 1229
  • [6] Anti-TNF Therapy in Elderly Patients With Inflammatory Bowel Disease in a Tuberculosis-Endemic Country
    Barros, Luisa Leite
    Cardoso de Azevedo, Matheus Freitas
    Carlos, Alexandre de Souza
    Lopes, Paula De Azevedo
    Fujita, Andre Okuhara
    Brito, Daniela Sanches
    Kamada, Daniela Midori
    Prado, Rita de Cassia Parente
    De Andrade, Julia Carvalho
    Oba, Jane
    Damiao, Aderson Omar Mourao Cintra
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (12S): : S9 - S9
  • [7] Targeted versus universal tuberculosis chemoprophylaxis in 1968 patients with inflammatory bowel disease receiving anti-TNF therapy in a tuberculosis endemic region
    Ye, Lingna
    Chapman, Thomas P.
    Wen, Zhenzhen
    Lin, Lang
    Qiu, Yun
    Liu, Zhanju
    Ran, Zhihua
    Qian, Jiaming
    Wu, Kaichun
    Gao, Xiang
    Hu, Pinjin
    Chen, Minhu
    Travis, Simon P. L.
    Cao, Qian
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (03) : 390 - 399
  • [8] Risk of tuberculosis with anti-TNF therapy in Indian patients with inflammatory bowel disease despite negative screening
    Giri, Suprabhat
    Bhrugumalla, Sukanya
    Shukla, Akash
    Gangadhar, Sagar
    Reddy, Srujan
    Angadi, Sumaswi
    Shinde, Leela
    Kale, Aditya
    ARAB JOURNAL OF GASTROENTEROLOGY, 2025, 26 (01) : 33 - 37
  • [9] Tuberculosis infection in inflammatory bowel disease patients after anti-TNF therapy in a high tuberculosis prevalence rate area
    De Castro, M. L.
    Hernandez, V.
    Pineda, J. R.
    Pereira, S.
    Martinez-Cadilla, J.
    Sanroman, L.
    Rodriguez-Prada, I.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S191 - S192
  • [10] Efficacy of tuberculosis (TB) screening guidelines for Anti-TNF alpha therapy in patients of endemic area.
    Ribeiro, Ana Regina
    Tizziani, Vivian A. P.
    Gonçalves, Deborah P.
    Guedes, Lissiane K. N.
    Kochen, Jussara A. L.
    Laurindo, Ieda M. M.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S629 - S630
12345